Clinical observation of the effect of umbilical cord blood stem cell transplantation in treatment of decompensated cirrhosis
10.3760/cma.j.issn.1673-4904.2014.22.005
- VernacularTitle:脐血干细胞移植治疗失代偿期肝硬化的早期临床疗效探讨
- Author:
Yanhong ZHU
;
Dazheng HAN
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis;
Umbilical cord blood stem cell transplantation;
Liver function
- From:
Chinese Journal of Postgraduates of Medicine
2014;37(22):15-17
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical eficacy of umbilical cord blood stem cell transplantation in treatment of decompensated cirrhosis.Methods Thirty patients with decompensated cirrhosis were given umbilical cord blood stem cell transplantation (treatment group) and 30 patients with decompensated cirrhosis were given traditional treatment (control group).Liver function and blood coagulation function was tested after 4,8 weeks treatment respectively,and adverse effects were recorded at the same time.Results After 8 weeks treatment,total bilirubin,albumin and prothrombin time in treatment group was improved compared with that before treatment[(71.3 ± 37.8) μ mol/L vs.(107.3 ± 53.2) μ mol/L,(30.1 ± 4.9) g/L vs.(27.5 ± 5.1) g/L,(15.0 ± 2.9) s vs.(16.7 ± 3.9) s],and there was significant difference (P ＜ 0.05).There was no significant difference in the index before and after treatment in control group (P＞ 0.05).No obvious adverse reactions were observed in the process of umbilical cord blood stem cell transplantation.Conclusion Umbilical cord blood stem cell transplantation is safe and effective in treatment of deeompensated cirrhosis.
